ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,883Medicare Part D Prescriptions Filled, Including Refills

Rank: 393 out of 6645

$1.2M Total Retail Price of All Prescriptions

Rank: 226 out of 6645

211 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
100% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

17% of this provider’s 211 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 12,231 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

44% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$86 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

66 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
IBUPROFEN 390 341 1 42
AMLODIPINE BESYLATE 345 281 2 2
ZOLPIDEM TARTRATE 329 281 3 17
OMEPRAZOLE 319 258 4 6
TAMSULOSIN HCL 317 277 5 22
NEXIUM 298 284 6 40
NAMENDA 295 280 7 41
DIOVAN 291 278 8 19
METFORMIN HCL 288 253 9 7
METOPROLOL TARTRATE 274 196 10 13
METOPROLOL SUCCINATE 268 256 11 24
CRESTOR 261 221 12 34
MELOXICAM 239 181 13 46
FUROSEMIDE 227 215 14 11
DONEPEZIL HCL 204 199 15 27
PLAVIX 199 151 16 49
HYDROCODONE-ACETAMINOPHEN 199 169 S3 16 5
VOLTAREN 190 168 18 108
CYMBALTA 190 168 18 78
SIMVASTATIN 189 160 20 1
ATENOLOL 177 144 21 8
TRAMADOL HCL 174 173 22 30
ACTOS 172 158 23 71
DIOVAN HCT 172 148 23 64
ADVAIR DISKUS 169 162 25 45
CELEBREX 166 155 26 54
TRIAMCINOLONE ACETONIDE 159 154 27 55
CREON 155 137 28 114
MECLIZINE HCL 152 109 29 122
ATORVASTATIN CALCIUM 149 120 30 10
LOVAZA 141 127 31 68
ZENPEP 140 123 32 210
GLYBURIDE 139 124 R 33 58
CARVEDILOL 137 109 34 25
ABILIFY 136 116 35 204
CLOPIDOGREL 135 119 36 36
VESICARE 124 110 37 148
ESCITALOPRAM OXALATE 119 59 38 86
LEVOTHYROXINE SODIUM 117 105 39 4
GLYBURIDE-METFORMIN HCL 112 111 R 40 95
ISOSORBIDE MONONITRATE ER 112 109 40 66
LIDODERM 110 100 42 53
DEXILANT 103 77 43 102
LIPITOR 100 100 44 69
GABAPENTIN 96 82 45 18
NIFEDIPINE ER 95 82 46 82
ALENDRONATE SODIUM 94 94 47 14
ENALAPRIL MALEATE 93 93 48 75
SINGULAIR 87 85 49 76
LEVOFLOXACIN 86 74 50 83
DIGOXIN 85 85 51 59
LISINOPRIL 79 67 52 3
AVODART 79 79 52 99
AMOXICILLIN 72 53 54 107
SERTRALINE HCL 71 63 55 43
ALLOPURINOL 71 60 55 31
RAMIPRIL 69 57 57 118
PROAIR HFA 68 49 58 32
JANUVIA 66 66 59 38
LYRICA 65 51 60 127
ZETIA 63 54 61 87
AMLODIPINE BESYLATE-BENAZEPRIL 63 63 61 97
LEXAPRO 63 47 61 218
NASONEX 60 59 64 126
BENAZEPRIL HCL 60 51 64 21
WARFARIN SODIUM 59 47 66 16
INSULIN SYRINGE 59 59 66 61
PAROXETINE HCL 59 48 66 72
COLCRYS 59 50 66 192
DETROL LA 57 57 70 260
NIFEDICAL XL 56 56 71 295
AGGRENOX 56 56 71 282
PATANOL 55 55 73 131
HYDROCHLOROTHIAZIDE 54 42 74 9
LOSARTAN-HYDROCHLOROTHIAZIDE 54 54 74 62
CLONIDINE HCL 53 44 76 56
DICLOFENAC SODIUM 52 52 77 109
BYSTOLIC 52 48 77 110
SUMATRIPTAN SUCCINATE 51 45 79 306
JANUMET 51 43 79 132
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 3, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.